MDA-MB-468 cell

SKU:BHC11101422
Featured Bulk Pricing
Overview
Click light‑blue chips for details

MDA-MB-468 cell is a cell line derived from African (Female). It is commonly used as an in vitro model for 1 research. Growth characteristics: Adherent, Epithelial. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Human
Disease model Adenocarcinoma
Morphology Epithelial
Growth Properties Adherent
Tissue Breast
Options selector
Catalog no. Size
300279 1 cryovial
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Field Specification
Mfr No 300279
Species Human
The MDA-MB-468 cell line is a well-established human breast cancer cell line derived from the pleural effusion of an adult patient with metastatic adenocarcinoma. These cells are characterized by their epithelial morphology and are known for their high degree of aneuploidy. MDA-MB-468 cells are estrogen receptor-negative (ER-) and are often used as a model to study triple-negative breast cancer (TNBC), a subtype of breast cancer that lacks estrogen receptor (ER), progesterone receptor (PR), and HER2/neu expression. This makes MDA-MB-468 a critical tool for research into cancers that do not respond to hormonal therapy or HER2-targeted treatments. Genetically, MDA-MB-468 cells exhibit mutations in the TP53 gene, which is a common occurrence in various forms of cancer and plays a significant role in cell cycle regulation and apoptosis. The cell line also shows amplification of the epidermal growth factor receptor (EGFR) gene, contributing to its utility in studying the EGFR signaling pathway and its implications in cancer progression and treatment resistance. Researchers frequently utilize MDA-MB-468 cells to investigate mechanisms of drug resistance, test new therapeutic agents, and explore the molecular biology of aggressive breast cancers. In addition to their genetic and phenotypic characteristics, MDA-MB-468 cells are known for their ability to form xenografts in immunocompromised mice, making them a valuable model for in vivo studies of tumor growth and metastasis. This cell line's responsiveness to various chemotherapeutic agents and targeted therapies is extensively studied to develop effective treatment strategies for TNBC. Overall, the MDA-MB-468 cell line is a crucial resource for advancing breast cancer research, particularly in the context of triple-negative and EGFR-positive malignancies.

SKU:BHC11101422

  • cultureMedium: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
  • supplements: Supplement the medium with 10% FBS
  • dissociationReagent: Accutase
  • subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
  • fluidRenewal: 2 to 3 times per week
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today